Results 231 to 240 of about 233,257 (341)
Transition rates to schizophrenia and early intervention effectiveness in substance-induced and brief psychotic disorders: a randomized controlled trial. [PDF]
Abouzed M +8 more
europepmc +1 more source
Abstract Objective Investigate the efficacy of immediate‐release (IR) amantadine in reducing the risk of peak‐dose dyskinesia in early Parkinson's disease (PD) as add‐on to levodopa. Background While the use of amantadine to manage dyskinesia in PD is well supported by controlled clinical trials, data on its efficacy in patients without motor ...
Olivier Rascol +106 more
wiley +1 more source
Anomalous self-experience in substance-induced and primary psychotic disorders: a cross-sectional comparative study using the EASE interview. [PDF]
De Risio L +6 more
europepmc +1 more source
Bipolar Disorder as a Long‐Term Risk Factor for Parkinson's Disease: A Nationwide Case–Control Study
Abstract Background Previous studies suggest an association between bipolar disorder (BD) and an increased risk of Parkinson's disease (PD), but the long‐term temporal relationship remains unclear. Particularly, it is unclear whether the risk of PD is influenced by the duration since BD diagnosis.
Elina Jaakkola +5 more
wiley +1 more source
Emotional intelligence mediated the association between interpersonal mindfulness and bullying victimization/perpetration (BV/BP). Higher interpersonal mindfulness was significantly associated with higher emotional intelligence. Higher emotional intelligence was significantly associated with lower BV/BP.
Marguerita Aoun +7 more
wiley +1 more source

